Bio-Techne revenue and financials
In the fiscal year ended June 2026, Bio-Techne reported revenue of $1.22B (−0.38% year over year). Net income was $181.86M, a net margin of 15.0%.
Fiscal year ending in June. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- −0.38%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +147.77%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 15.0%
- FY to Jun 2025: 6.0%
How Bio-Techne is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 5.5% a year on average over the last 5 years
Compound annual growth rate: from $931.03M in 2021 to $1.22B in 2026.
Operating margin fell from 26.3% to 20.7%
Operating income over revenue, 2023 → 2026: 5.6 percentage points.
Profits turn into cash: free cash flow equal to 179% of net income
Totals for fiscal years 2024–2026: free cash flow $755.88M, net income $423.37M.
Shares outstanding down 3.0% in 5 years
Average diluted shares, 2021 → 2026: with fewer shares, each one represents a larger stake in the company.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,215 | 1,220 | 1,159 | 1,137 | 1,106 | 931 | 739 | 714 | 643 | 563 |
| Cost of revenue | 416 | 429 | 389 | 367 | 349 | 298 | 255 | 241 | 211 | 188 |
| Gross profit | 799 | 790 | 770 | 770 | 756 | 633 | 483 | 473 | 432 | 375 |
| Selling, general and administrative | 436 | 488 | 429 | 397 | 392 | 312 | 267 | 262 | 216 | 175 |
| Research and development | 94.8 | 99.5 | 96.7 | 92.5 | 87.1 | 70.6 | 65.2 | 62.4 | 55.3 | 53.5 |
| Operating income | 252 | 102 | 207 | 299 | 297 | 237 | 157 | 147 | 136 | 121 |
| EBIT | 275 | 223 | 249 | 281 | 279 | 251 | 151 | 153 | 163 | 149 |
| EBITDA | 334 | 289 | 314 | 344 | 340 | 303 | 199 | 198 | 203 | 186 |
| Interest expense | 9.6 | 8.5 | 15.7 | 11.2 | 11.3 | 14.0 | 19.2 | 21.7 | 10.2 | 7.4 |
| Pre-tax income | 241 | 98.5 | 186 | 339 | 301 | 148 | 276 | 112 | 126 | 112 |
| Income tax | 58.8 | 25.1 | 17.6 | 53.2 | 38.3 | 8.6 | 47.2 | 15.9 | -0.2 | 35.9 |
| Net income | 182 | 73.4 | 168 | 285 | 272 | 140 | 229 | 96.1 | 126 | 76.1 |
| Net income to common shareholders | 182 | 73.4 | 168 | 285 | 272 | 140 | 229 | 96.0 | 126 | 76.0 |
| Basic EPS | 1.17 | 0.47 | 1.07 | 1.81 | 1.73 | 0.91 | 6.00 | 2.54 | 3.36 | 2.04 |
| Diluted EPS | 1.16 | 0.46 | 1.05 | 1.76 | 1.66 | 0.87 | 5.82 | 2.47 | 3.31 | 2.03 |
| Average shares (basic) | 156 | 158 | 158 | 157 | 157 | 155 | 153 | 151 | 150 | 149 |
| Average shares (diluted) | 157 | 160 | 161 | 162 | 164 | 162 | 39.4 | 38.9 | 38.1 | 37.5 |
| Dividend per share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 300 | 321 | 311 | 296 | 287 | 317 | 316 | 297 | 289 | 306 | 303 | 273 |
| Cost of revenue | 102 | 109 | 102 | 103 | 96.4 | 106 | 101 | 100 | 101 | 101 | 98.0 | 94.7 |
| Gross profit | 198 | 212 | 209 | 193 | 190 | 211 | 215 | 197 | 188 | 205 | 205 | 178 |
| Selling, general and administrative | 131 | 98.6 | 108 | 112 | 118 | 102 | 151 | 121 | 114 | 109 | 108 | 106 |
| Research and development | 26.3 | 23.9 | 23.5 | 23.1 | 24.2 | 26.0 | 24.6 | 25.0 | 23.9 | 18.2 | 25.8 | 22.9 |
| Operating income | 40.3 | 89.5 | 78.4 | 58.2 | 48.4 | 82.9 | 39.5 | 50.6 | 50.4 | 77.9 | 72.0 | 49.1 |
| EBIT | 40.3 | 89.5 | 78.4 | 58.2 | 48.4 | 82.9 | 39.5 | 50.6 | 50.4 | 77.9 | 72.0 | 49.1 |
| EBITDA | 64.0 | 114 | 103 | 82.9 | 72.7 | 110 | 67.1 | 77.7 | 78.6 | 106 | 99.3 | 76.9 |
| Interest expense | 2.2 | 2.1 | 2.4 | 2.2 | 2.9 | 2.2 | 2.0 | 2.1 | 2.2 | 2.5 | 4.0 | 4.3 |
| Pre-tax income | 34.7 | 70.7 | 71.2 | 50.8 | 48.0 | -22.9 | 38.3 | 42.9 | 40.2 | 41.7 | 61.1 | 33.4 |
| Income tax | 6.4 | 16.1 | 20.2 | 12.8 | 9.8 | -5.2 | 15.7 | 8.0 | 6.6 | 1.1 | 12.0 | 5.9 |
| Net income | 28.3 | 54.6 | 51.0 | 38.0 | 38.2 | -17.7 | 22.6 | 34.9 | 33.6 | 40.6 | 49.1 | 27.5 |
| Net income to common shareholders | 28.3 | 54.6 | 51.0 | 38.0 | 38.2 | -17.7 | 22.6 | 34.9 | 33.6 | 40.6 | 49.1 | 27.5 |
| Basic EPS | 0.18 | 0.35 | 0.33 | 0.24 | 0.25 | -0.11 | 0.14 | 0.22 | 0.21 | 0.26 | 0.31 | 0.17 |
| Diluted EPS | 0.18 | 0.35 | 0.32 | 0.24 | 0.24 | -0.12 | 0.14 | 0.22 | 0.21 | 0.26 | 0.31 | 0.17 |
| Average shares (basic) | 157 | 156 | 156 | 156 | 155 | 155 | 157 | 158 | 159 | 158 | 157 | 158 |
| Average shares (diluted) | 158 | 157 | 157 | 157 | 156 | 156 | 159 | 161 | 161 | 161 | 160 | 160 |
| Dividend per share | — | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,587 | 2,558 | 2,704 | 2,639 | 2,295 | 2,263 | 2,028 | 1,884 | 1,593 | 1,558 |
| Current assets | 744 | 608 | 617 | 621 | 606 | 511 | 521 | 413 | 398 | 348 |
| Cash and equivalents | 265 | 162 | 152 | 181 | 173 | 199 | 147 | 101 | 122 | 91.6 |
| Short-term investments | 0.8 | 0.0 | 1.1 | 23.7 | 74.5 | 32.5 | 124 | 65.1 | 59.8 | 66.1 |
| Receivables | 217 | 207 | 241 | 218 | 195 | 145 | 123 | 137 | 120 | 117 |
| Inventory | 196 | 189 | 180 | 172 | 141 | 117 | 103 | 91.1 | 85.6 | 60.2 |
| Net property, plant and equipment | 299 | 319 | 342 | 325 | 289 | 282 | 248 | 154 | 145 | 135 |
| Goodwill | 975 | 981 | 973 | 873 | 822 | 843 | 728 | 733 | 598 | 579 |
| Other intangible assets | 303 | 366 | 507 | 535 | 532 | 616 | 517 | 579 | 446 | 452 |
| Long-term investments | 246 | 251 | 252 | 273 | 36.0 | 0.3 | — | — | 2.6 | 40.4 |
| Current liabilities | 164 | 176 | 159 | 129 | 176 | 152 | 107 | 102 | 79.5 | 136 |
| Accounts payable | 26.7 | 25.3 | 38.0 | 25.7 | 33.9 | 29.4 | 23.1 | 16.2 | 18.5 | 16.9 |
| Long-term debt | 200 | 346 | 319 | 350 | 243 | 329 | 344 | 493 | 339 | 344 |
| Total debt | 289 | 444 | 420 | 455 | 326 | 429 | 451 | 518 | 339 | 344 |
| Total liabilities | 479 | 639 | 635 | 672 | 594 | 692 | 646 | 719 | 514 | 609 |
| Total equity (incl. minority) | 2,108 | 1,919 | 2,069 | 1,967 | 1,701 | 1,571 | 1,381 | 1,166 | 1,079 | 950 |
| Retained earnings | 1,144 | 1,066 | 1,325 | 1,309 | 1,123 | 1,085 | 1,057 | 932 | 877 | 799 |
| Minority interest | — | 0.0 | 0.0 | 0.0 | -0.8 | 8.3 | — | — | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,637 | 2,587 | 2,551 | 2,523 | 2,526 | 2,558 | 2,644 | 2,670 | 2,736 | 2,704 | 2,721 | 2,731 |
| Current assets | 825 | 744 | 688 | 637 | 610 | 608 | 627 | 635 | 649 | 617 | 611 | 591 |
| Cash and equivalents | 350 | 265 | 210 | 173 | 145 | 162 | 141 | 178 | 188 | 152 | 140 | 130 |
| Short-term investments | 1.1 | 0.8 | 4.3 | 6.7 | — | 0.0 | 0.0 | — | — | 1.1 | 5.4 | 5.5 |
| Receivables | 203 | 217 | 215 | 185 | 184 | 207 | 237 | 218 | 224 | 241 | 228 | 207 |
| Inventory | 198 | 196 | 201 | 205 | 203 | 189 | 191 | 188 | 185 | 180 | 179 | 181 |
| Net property, plant and equipment | 292 | 299 | 301 | 303 | 311 | 319 | 336 | 335 | 343 | 342 | 341 | 335 |
| Goodwill | 972 | 975 | 978 | 981 | 979 | 981 | 969 | 965 | 983 | 973 | 971 | 980 |
| Other intangible assets | 287 | 303 | 319 | 335 | 350 | 366 | 444 | 461 | 486 | 507 | 526 | 551 |
| Long-term investments | 246 | 246 | 246 | 250 | 259 | 251 | 255 | 260 | 263 | 252 | 260 | 261 |
| Current liabilities | 361 | 164 | 153 | 140 | 145 | 176 | 169 | 161 | 142 | 159 | 150 | 135 |
| Accounts payable | 31.0 | 26.7 | 23.5 | 26.3 | 30.2 | 25.3 | 31.6 | 33.1 | 31.6 | 38.0 | 28.9 | 31.5 |
| Long-term debt | — | 200 | 200 | 260 | 300 | 346 | 330 | 300 | 300 | 319 | 389 | 447 |
| Total debt | 286 | 289 | 290 | 351 | 394 | 444 | 423 | 395 | 399 | 420 | 495 | — |
| Total liabilities | 471 | 479 | 465 | 512 | 560 | 639 | 626 | 592 | 597 | 635 | 707 | 767 |
| Total equity (incl. minority) | 2,166 | 2,108 | 2,085 | 2,011 | 1,966 | 1,919 | 2,018 | 2,078 | 2,139 | 2,069 | 2,014 | 1,964 |
| Retained earnings | 1,153 | 1,144 | 1,145 | 1,107 | 1,083 | 1,066 | 1,196 | 1,287 | 1,341 | 1,325 | 1,298 | 1,261 |
| Minority interest | — | — | — | — | — | 0.0 | — | — | — | — | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 292 | 288 | 299 | 254 | 325 | 352 | 205 | 182 | 170 | 144 |
| Depreciation and amortization | 97.4 | 110 | 112 | 107 | 101 | 87.7 | 82.7 | 78.2 | 64.5 | 60.0 |
| Capital expenditure | -28.9 | -31.0 | -62.9 | -38.2 | -44.9 | -44.3 | -51.7 | -25.4 | -20.9 | -15.2 |
| Investing cash flow | -18.2 | -35.2 | -203 | -266 | -96.9 | -244 | 27.1 | -337 | -38.7 | -306 |
| Financing cash flow | -169 | -254 | -122 | 22.6 | -243 | -62.6 | -184 | 134 | -99.2 | 189 |
| Dividends paid | -49.9 | -50.4 | -50.4 | -50.3 | -50.2 | -49.6 | -48.9 | -48.4 | -48.0 | -47.3 |
| Share repurchases | -41.7 | -276 | -80.0 | -19.6 | -161 | -43.2 | -50.1 | -15.4 | 0.0 | — |
| Debt issued | 0.0 | 104 | 225 | 620 | 90.0 | 256 | 40.0 | 580 | 55.0 | 369 |
| Debt repaid | -146 | -77.0 | -256 | -526 | -176 | -272 | -189 | -414 | -59.5 | -117 |
| Effect of exchange rates | -2.2 | 11.9 | -2.3 | -3.4 | -12.1 | 6.4 | -2.8 | -0.3 | -2.1 | 0.5 |
| Net change in cash | 103 | 10.4 | -28.8 | 8.0 | -26.5 | 52.5 | 45.7 | -21.1 | 30.4 | 27.4 |
| Free cash flow | 263 | 257 | 236 | 216 | 280 | — | — | — | — | — |
| Levered free cash flow | 230 | 288 | 216 | 184 | 214 | 257 | 139 | 148 | 85.5 | 201 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 73.1 | 95.4 | 86.7 | 82.4 | 27.6 | 98.2 | 41.1 | 84.3 | 63.9 | 75.5 | 81.0 | 83.1 |
| Depreciation and amortization | 23.7 | -13.7 | 24.2 | 24.7 | 24.3 | -16.9 | 27.6 | 27.1 | 28.1 | -18.5 | 27.3 | 27.8 |
| Capital expenditure | -5.9 | -8.5 | -9.1 | -5.9 | -5.4 | -4.9 | -10.1 | -6.8 | -9.2 | -18.0 | -16.4 | -14.9 |
| Investing cash flow | -3.9 | -7.1 | -5.8 | -5.9 | 0.6 | 0.4 | -8.9 | -5.0 | -21.7 | -8.8 | -16.4 | -23.7 |
| Financing cash flow | 16.4 | -33.2 | -42.7 | -49.0 | -44.2 | -90.5 | -68.0 | -83.8 | -11.6 | -60.1 | -52.4 | -81.4 |
| Dividends paid | -12.6 | -12.5 | -12.5 | -12.5 | -12.4 | -12.4 | -12.6 | -12.7 | -12.7 | -12.6 | -12.6 | -12.6 |
| Share repurchases | -7.2 | -43.1 | -0.2 | -1.3 | -9.3 | -100 | -100 | -76.6 | -5.0 | -0.4 | -0.2 | -81.1 |
| Debt issued | — | 0.0 | — | — | — | 66.0 | 38.0 | — | — | 0.0 | 0.0 | 65.0 |
| Debt repaid | 0.0 | 0.0 | -60.0 | -40.0 | -46.0 | -50.0 | -8.0 | 0.0 | -19.0 | -70.0 | -58.0 | -58.0 |
| Effect of exchange rates | -0.2 | -0.3 | -1.2 | 0.4 | -1.2 | 13.4 | -1.1 | -5.5 | 5.1 | 5.3 | -2.3 | 3.4 |
| Net change in cash | 85.3 | 54.9 | 36.9 | 27.9 | -17.2 | 21.5 | -36.9 | -10.0 | 35.7 | 11.9 | 9.8 | -18.5 |
| Free cash flow | 67.2 | 86.9 | 77.6 | 76.5 | 22.2 | 93.3 | 31.0 | 77.5 | 54.7 | 57.5 | 64.5 | 68.3 |
| Levered free cash flow | 57.8 | 80.2 | 58.9 | 56.4 | 9.7 | 124 | 18.8 | 73.6 | 45.0 | 74.6 | 57.3 | 35.7 |
Financial statements of similar companies
Companies in the group: same industry, similar size
